Kit Check Closes $15 Million Series C Round Baxter Ventures Leads Round; Black Granite Capital, Kaiser Permanente Ventures, Rex Health Ventures, New Leaf Venture Partners, Easton Capital Management, LionBird and Sands Capital Ventures Participate Kit...
Merck to Acquire Afferent Pharmaceuticals KENILWORTH, N.J. & SAN MATEO, Calif., June 9, 2016 – Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Afferent Pharmaceuticals announced today that the two companies have signed a definitive...
Arvinas Publishes First Peer-Reviewed, In Vivo Data from its Proprietary PROTAC Technology PROTACs demonstrated to degrade oncology target BET proteins, causing cell death in prostate cancer cells and tumor growth inhibition or regression in mouse models of prostate...
TigerConnect Healthcare Bot Set to Automate the Future of Healthcare Information Bot-driven technology puts a “care coach” in the pocket of every patient in America Opens door to auto-diagnoses, drug interaction alerts, medication reminders, billing questions, and...
Afferent Pharmaceuticals Presents Updated Positive Results with AF-219 from Phase 2B Chronic Cough Study at the 2016 American Thoracic Society (ATS) International Conference Treatment with AF-219 reduced cough frequency by 50% or more at 50 mg BID dose in half of...
Recent Comments